Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,127 | 16,122 | 22,413 | 16,872 | 19,877 |
| Receivables | 344 | 397 | 180 | 217 | 139 |
| Other current assets | 85 | 83 | 193 | 448 | 1,251 |
| TOTAL | $11,336 | $18,585 | $24,007 | $18,997 | $23,052 |
| Non-Current Assets | |||||
| PPE Net | 56 | 67 | 79 | 59 | 65 |
| Other Non-Current Assets | 395 | 496 | 578 | 621 | 518 |
| TOTAL | $451 | $562 | $657 | $680 | $584 |
| Total Assets | $11,787 | $19,147 | $24,663 | $19,677 | $23,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,198 | 3,986 | 4,209 | 3,247 | 3,760 |
| TOTAL | $4,449 | $4,302 | $4,524 | $3,564 | $4,044 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 231 | 816 | 1,615 | 1,577 | 1,564 |
| TOTAL | $231 | $816 | $1,615 | $1,577 | $1,564 |
| Total Liabilities | $4,681 | $5,118 | $6,139 | $5,142 | $5,608 |
| Shareholders' Equity | |||||
| Common Shares | 67,597 | 70,684 | 53,910 | 53,683 | 54,087 |
| Retained earnings | -354,282 | -362,643 | -360,022 | -353,689 | -352,401 |
| Other shareholders' equity | 28,975 | 28,724 | 26,933 | 17,461 | 16,922 |
| TOTAL | $7,107 | $14,029 | $18,524 | $14,535 | $18,027 |
| Total Liabilities And Equity | $11,787 | $19,147 | $24,663 | $19,677 | $23,635 |